Anzeige
Mehr »
Login
Freitag, 21.02.2020 Börsentäglich über 12.000 News von 619 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FierceBiotech

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
22.01.'Does intrinsically good and bad technology exist?' Bayer CEO says no: Davos 2020
22.01.Kintai's obesity drug that works via the gut microbiome moves closer to the clinic
22.01.Respiratory device maker Vyaire Medical taps new CEO
22.01.With phase 2 in the bag, Akcea to test triglyceride-buster in FCS
22.01.Targovax plans checkpoint combo trial after posting early data on oncolytic virus
22.01.Notable Labs launches rolling blood cancer trial to test its AI system
22.01.Korean VCs pile into PDC*line to bankroll NSCLC vaccine trial
21.01.Roche, Inotrem extend collaboration on blood test for septic shock
21.01.GSK nabs speedy review for one of its top prospects
21.01.WHO berates 'lack of innovation' when it comes to antibiotic pipeline
21.01.Chi-Med stops pivotal pancreatic cancer trial upon early success
21.01.Revolution files for $100M IPO to advance KRAS candidates
21.01.GSK bets on tech to help boost lagging R&D as it looks to start 23andMe trial
21.01.LabCorp's CRO unit Covance doubles down on cell, gene therapy offerings
17.01.Fitbit for the flu: Researchers show the fitness wearables can help track outbreaks
17.01.Foxconn backs digital X-ray startup Nanox's $26M round
17.01.JPM: Biotech, VC execs on where the industry should look beyond cancer
17.01.Durect's painkiller gets evenly split decision from expert panel
17.01.After closing one of China's biggest-ever raises, I-Mab Biopharma nabs $104M Nasdaq IPO
17.01.Frazier closes $617M life science fund, creating scope for bigger bets
16.01.EuroBiotech Report-MorphoSys-Incyte, Adaptimmune deal, Galapagos, BioNTech and Ipsen
16.01.EuroBiotech: More Articles of Note
16.01.JPM: In conversation with Steve Paul, CEO of Karuna Therapeutics
16.01.Pfizer teams up with Insilico to mine data for drug targets
16.01.After IPO, BioNTech nabs cell therapy startup Neon Therapeutics